6039

Dali Pharmaceuticalco.,Ltd Stock Price

SHSE:603963 Community·CN¥259.2m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

603963 Share Price Performance

CN¥0
0.00 (0.00%)
CN¥0
0.00 (0.00%)
Price CN¥0

603963 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Mediocre balance sheet very low.

2 Risks
0 Rewards

Dali Pharmaceuticalco.,Ltd Key Details

CN¥61.6m

Revenue

CN¥53.4m

Cost of Revenue

CN¥8.3m

Gross Profit

CN¥32.6m

Other Expenses

-CN¥24.4m

Earnings

Last Reported Earnings
Sep 30, 2024
Next Reporting Earnings
Apr 25, 2025
-0.11
13.41%
-39.55%
5.4%
View Full Analysis

About 603963

Founded
1996
Employees
272
CEO
Jun Xiang Yang
WebsiteView website
www.daliyaoye.cn

Dali Pharmaceuticalco.,Ltd researches, develops, produces, and sells pharmaceutical products in China. It develops Chinese and Western medicine injection. The company’s products include xingnaojing, shenmai, and astragalus injections, as well as citicoline injections. It also has patents, including invention patents and utility models. The company was founded in 1996 and is headquartered in Dali, China.

Recent 603963 News & Updates

Recent updates

No updates